Annovis Bio CEO Discusses Trial Results

Published: March 22, 2021, 8:09 p.m.

b"The President and CEO of Annovis Bio (ANVS) Maria Maccecchini joins Nicole to discuss the biotechnology sector and her company, which has recently issued preliminary data on its treatments for Alzheimer's and Parkinson's as well as other neurodegenerative diseases."